Spain · AEMPS CIMA
COMIRNATY ORIGINAL/OMICRON BA.1 (15/15 MICROGRAMOS)/DOSIS DISPERSION INYECTABLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 1201528006
- Form
- DISPERSIÓN INYECTABLE
- Composition / generic term
- vacuna anti COVID-19 (Pfizer/BioNTech) riltozinamerán + tozinamerán
- Source strength
- 15 MICROGRAMOS/15 MICROGRAMOS
- Authorisation holder
- Biontech Manufacturing Gmbh
- Marketed in source snapshot
- No
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
- Professional information (original source)
- Patient leaflet (original source)
- Official document (original source)
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →